搜索临床试验以:VIR-2218
总计3413个结果
-
Michigan State UniversityNational Cancer Institute (NCI)完全的
-
University Hospital Bispebjerg and Frederiksberg撤销
-
Bayer完全的
-
Zai Lab (Hong Kong), Ltd.Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.招聘中
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad Javeriana完全的
-
University of California, IrvineMassachusetts General Hospital; Nationwide Children's Hospital; California State University, Fullerton 和其他合作者完全的
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)招聘中急性髓性白血病 | 原始细胞过多的骨髓增生异常综合征 2澳大利亚, 奥地利, 比利时, 爱沙尼亚, 芬兰, 法国, 德国, 爱尔兰, 立陶宛, 卢森堡, 荷兰, 挪威, 西班牙, 瑞典, 瑞士
-
Centre Hospitalier Régional d'Orléans完全的
-
Islamia University of BahawalpurGerman University in Cairo完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Novo Nordisk A/S完全的
-
Assistance Publique - Hôpitaux de Paris招聘中
-
University of MichiganNational Institute of Mental Health (NIMH)邀请报名
-
Michigan State University招聘中
-
Memorial Sloan Kettering Cancer CenterThe City College of New York; North Jersey Community Research Initiative; Gay Men's Health Crisis 和其他合作者完全的
-
Coopervision, Inc.完全的
-
Amgen招聘中
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.终止
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics...完全的
-
University of CologneEthicon Endo-Surgery (Europe) GmbH未知